Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model-Reference-Cited by-同舟云学术

Design, synthesis and binding mode of interaction of novel small molecule o-hydroxy benzamides as HDAC3-selective inhibitors with promising antitumor effects in 4T1-Luc breast cancer xenograft model

Published:2021-12 Issue: Volume:117 Page:105446
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Routholla Ganesh,Pulya Sravani,Patel Tarun,Adhikari Nilanjan,Abdul Amin Sk.,Paul Milan,Bhagavatula Srividya,Biswas Swati,Jha Tarun,Ghosh Balaram

Funder

Department of Science and Technology

Council of Scientific & Industrial Research

Science and Engineering Research Board

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference68 articles.

1. Thioether-based 2-aminobenzamide derivatives: Novel HDAC inhibitors with potent in vitro and in vivo antitumor activity;Yun;Eur. J. Med. Chem.,2019

2. Cause and consequences of genetic and epigenetic alterations in human cancer;Sadikovic;Curr. Genom.,2008

3. Histone acetylation and disease;Timmermann;Cell. Mol. Life Sci.,2001

4. Regulating histone acetyltransferases and deacetylases;Legube;EMBO Rep.,2003

5. Histone deacetylase inhibitors: Inducers of differentiation or apoptosis of transformed cells;Marks;J. Natl. Cancer. Inst.,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis, characterization and bioactivity of new pyridine-2(H)-one, nicotinonitrile, and furo[2,3-b]pyridine derivatives;Molecular Diversity;2024-07-16

2. Epigenetic modulations in triple-negative breast cancer: Therapeutic implications for tumor microenvironment;Pharmacological Research;2024-06

3. Caspase‐driven cancer therapies: Navigating the bridge between lab discoveries and clinical applications;Cell Biochemistry and Function;2024-02-13

4. Human Serum Albumin-Oxaliplatin (Pt(IV)) prodrug nanoparticles with dual reduction sensitivity as effective nanomedicine for triple-negative breast cancer;International Journal of Biological Macromolecules;2024-01

5. Technologies of targeting histone deacetylase in drug discovery: Current progress and emerging prospects;European Journal of Medicinal Chemistry;2023-12